Strata Critical Medical, Inc. (SRTA)
NASDAQ: SRTA · Real-Time Price · USD
5.33
+0.51 (10.58%)
At close: May 6, 2026, 4:00 PM EDT
5.29
-0.04 (-0.75%)
After-hours: May 6, 2026, 7:59 PM EDT

Strata Critical Medical Statistics

Total Valuation

SRTA has a market cap or net worth of $460.76 million. The enterprise value is $406.44 million.

Market Cap460.76M
Enterprise Value 406.44M

Important Dates

The last earnings date was Wednesday, May 6, 2026, before market open.

Earnings Date May 6, 2026
Ex-Dividend Date n/a

Share Statistics

SRTA has 86.45 million shares outstanding. The number of shares has increased by 7.82% in one year.

Current Share Class 86.45M
Shares Outstanding 86.45M
Shares Change (YoY) +7.82%
Shares Change (QoQ) +6.46%
Owned by Insiders (%) 13.73%
Owned by Institutions (%) 52.93%
Float 61.65M

Valuation Ratios

The trailing PE ratio is 9.46.

PE Ratio 9.46
Forward PE n/a
PS Ratio 2.02
Forward PS 1.68
PB Ratio 1.61
P/TBV Ratio 3.05
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings 8.65
EV / Sales 1.78
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 5.93, with a Debt / Equity ratio of 0.02.

Current Ratio 5.93
Quick Ratio 4.70
Debt / Equity 0.02
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -6.35% and return on invested capital (ROIC) is -2.38%.

Return on Equity (ROE) -6.35%
Return on Assets (ROA) -2.14%
Return on Invested Capital (ROIC) -2.38%
Return on Capital Employed (ROCE) -3.23%
Weighted Average Cost of Capital (WACC) 15.92%
Revenue Per Employee $699,012
Profits Per Employee $143,713
Employee Count327
Asset Turnover 0.79
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +87.02% in the last 52 weeks. The beta is 2.15, so SRTA's price volatility has been higher than the market average.

Beta (5Y) 2.15
52-Week Price Change +87.02%
50-Day Moving Average 4.52
200-Day Moving Average 4.71
Relative Strength Index (RSI) 65.88
Average Volume (20 Days) 747,320

Short Selling Information

The latest short interest is 5.91 million, so 6.83% of the outstanding shares have been sold short.

Short Interest 5.91M
Short Previous Month 7.42M
Short % of Shares Out 6.83%
Short % of Float 9.58%
Short Ratio (days to cover) 8.81

Income Statement

In the last 12 months, SRTA had revenue of $228.58 million and earned $46.99 million in profits. Earnings per share was $0.56.

Revenue228.58M
Gross Profit 48.19M
Operating Income -9.90M
Pretax Income -16.05M
Net Income 46.99M
EBITDA -1.64M
EBIT -9.90M
Earnings Per Share (EPS) $0.56
Full Income Statement

Balance Sheet

The company has $58.79 million in cash and $4.47 million in debt, with a net cash position of $54.32 million or $0.63 per share.

Cash & Cash Equivalents 58.79M
Total Debt 4.47M
Net Cash 54.32M
Net Cash Per Share $0.63
Equity (Book Value) 285.73M
Book Value Per Share 3.30
Working Capital 103.20M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$44.78 million and capital expenditures -$12.16 million, giving a free cash flow of -$56.94 million.

Operating Cash Flow -44.78M
Capital Expenditures -12.16M
Depreciation & Amortization 8.26M
Net Borrowing n/a
Free Cash Flow -56.94M
FCF Per Share -$0.66
Full Cash Flow Statement

Margins

Gross margin is 21.08%, with operating and profit margins of -4.33% and 20.56%.

Gross Margin 21.08%
Operating Margin -4.33%
Pretax Margin -7.02%
Profit Margin 20.56%
EBITDA Margin -0.72%
EBIT Margin -4.33%
FCF Margin n/a

Dividends & Yields

SRTA does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -7.82%
Shareholder Yield -7.82%
Earnings Yield 10.20%
FCF Yield -12.36%

Analyst Forecast

The average price target for SRTA is $7.81, which is 46.53% higher than the current price. The consensus rating is "Strong Buy".

Price Target $7.81
Price Target Difference 46.53%
Analyst Consensus Strong Buy
Analyst Count 4
Revenue Growth Forecast (5Y) 16.25%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1